Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Opus Genetics, Inc. (IRD) had Free Cash Flow per Share of $-0.27 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$4.37M |
|
$-8.19M |
|
-- |
|
$4.37M |
|
$14.30M |
|
$-9.93M |
|
$1.74M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-9.93M |
|
$-9.92M |
|
33.88M |
|
33.88M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$47.93M |
|
$0.24M |
|
$0.24M |
|
$48.17M |
|
$24.25M |
|
-- |
|
$18.84M |
|
$43.09M |
|
$5.07M |
|
$5.07M |
|
$5.07M |
|
45.48M |
|
| Cash Flow Statement Financials | |
$-8.99M |
|
-- |
|
$20.46M |
|
$30.32M |
|
$41.79M |
|
$11.47M |
|
$0.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-227.21% |
|
-227.21% |
|
-- |
|
-187.51% |
|
-187.51% |
|
$-8.99M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
1.42 |
|
63.43 |
|
-161.52% |
|
-161.52% |
|
-17.01% |
|
-161.52% |
|
$0.11 |
|
|
Free Cash Flow per Share |
$-0.27 |
$-0.27 |
|